Ruth O'Regan, MD, associate professor of hematology and oncology at Emory University's Winship Cancer Institute, has been selected as the Medical Honoree at the 2006 Komen Atlanta Pink Tie Ball. The Komen Atlanta ball, which will be held at the Grand Hyatt in Buckhead on Saturday, Oct. 14, 2006, is one of Atlanta's most prominent and well attended fund raisers.
"Dr. O'Regan is conducting groundbreaking work in breast cancer research, treatment and support," said Kelly Dolan, executive director of the Atlanta affiliate of the Susan G. Komen Breast Cancer Foundation. "We are delighted to be able to honor Dr. O'Regan for the innovative and important work she is doing."
Dr. O'Regan is widely published in peer-reviewed scientific journals, having published articles in journals such as Lancet Oncology, the Journal of the National Cancer Institute and the Journal of the American Medical Association. She is a member of numerous boards and scientific committees, among them the Breast Cancer Scientific Committee of the American Society of Clinical Oncology.
A native of Dublin, Ireland, Dr. O'Regan earned her medical degree at University College in Dublin. She conducted a residency in Internal Medicine and a Fellowship in Oncology at the Mater Hospital in Dublin. She did her U.S. residency and fellowship at Northwestern University, Chicago, and joined the faculty there in 1999. While at Northwestern, she researched the mechanisms of selective estrogen receptor modulator or SERM resistance. In addition, she won the Compassionate Care Award from the Women's Board of Northwestern Hospital and the NSABP Young Clinical Investigator Award in 2001.
Since joining the faculty at Winship, she has continued her research in SERM resistance. Additionally, her laboratory focuses on the use of nanoparticles conjugated to antibodies to detect and quantify proteins important in breast carcinogenesis. A Georgia Cancer Coalition Distinguished Cancer Scholar, Dr. O'Regan is principal investigator of the first trial to be run through Georgia Cancer Coalition's innovative Georgia CORE (Center for Oncology Research and Education). She has developed a multidisciplinary breast cancer clinic at the Grady Cancer Center of Excellence and serves as Director of the Glenn Family Breast Cancer Fund, conducting research into the differences in molecular profiling in pre- and post-menopausal women. Dr. O'Regan also is co-director of the Jean Sindab Project Research Team, which focuses on developing scientific research into breast cancer in African American women.
The Komen Atlanta Pink Tie Ball is a formal dinner-dance to raise funds for breast cancer research, education and treatment programs. Seventy-five percent of all funds raised by the Atlanta Affiliate are awarded to local breast health projects and programs. Twenty-five percent of the funds are given to the national Komen Research Grant Program. The 2006 Pink Tie Ball, one of Atlanta's largest gala events, is expected to raise more than $750,000 for breast cancer research, education, screening and treatment.
For more information, log on to www.komen-atlanta.org or call 404-459-8700.